Loading...
Market
Primary market target for Enifer's mycoprotein by 2025
5
Resolution / Starting Odds
Europe • 33%
North America • 33%
Asia • 33%
Company marketing materials or statements in credible business publications.
Story
Finnish Startup Enifer Secures €36M for Mycoprotein Factory in Finland
May 23, 2024, 09:10 AM
Finnish biotech startup Enifer has secured €36 million ($39.1 million) in funding to build a large-scale mycoprotein factory in Finland. The funding, a mix of debt and equity, will be used to construct the first factory to produce fungal protein from sidestream materials. This facility aims to address the global protein shortage by producing up to 3,000 tons of food-grade mycoprotein annually. Enifer's innovative approach involves feeding a microbe air and electricity to create protein, showcasing a sustainable alternative to traditional agriculture. The project has garnered support from various investors, including Voima Ventures, FoodTech VC, Taaleri Team, Valio Ltd, and FinnveraFi.
View original story
Similar markets
Low penetration (<1%) • 25%
Moderate penetration (1-3%) • 25%
High penetration (3-5%) • 25%
Very high penetration (>5%) • 25%
No adoption • 33%
Adoption by 1-3 companies • 33%
Adoption by 4 or more companies • 34%
Below 5000 tons • 25%
5000 to 10000 tons • 25%
10000 to 15000 tons • 25%
Above 15000 tons • 25%
Top 10 globally • 25%
Top 50 globally • 25%
No significant change • 25%
Loses market position • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
North America • 25%
Europe • 25%
Asia • 25%
Rest of World • 25%
High market adoption • 33%
Moderate market adoption • 33%
Low market adoption • 33%
North America • 25%
Europe • 25%
Asia • 25%
Rest of the World • 25%
Adopted in 1-5 countries • 25%
Adopted in 6-10 countries • 25%
Adopted in 11-20 countries • 25%
Adopted in 21 or more countries • 25%